APA
BMY icon

Astoria Portfolio Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Astoria Portfolio Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+3,611
New +$207K 0.04% 340
2025
Q1 		– Sell
-6,140
Closed -$342K – 241
2024
Q4 		$342K Sell
6,140
-42
-0.7% -$2.35K 0.12% 143
2024
Q3 		$323K Buy
6,182
+475
+8% +$22.3K 0.11% 140
2024
Q2 		$237K Buy
5,707
+672
+13% +$30.1K 0.08% 161
2024
Q1 		$244K Sell
5,035
-79
-2% -$4.02K 0.09% 151
2023
Q4 		$252K Buy
+5,114
New +$268K 0.1% 152

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Astoria Portfolio Advisors's BMY Position: Q2 2026 in Review

Astoria Portfolio Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 3,611 shares worth $208K. The stake represents 0.04% of the portfolio and ranks #340 among its holdings. This is a return to the name: Astoria Portfolio Advisors previously reported a position in BMY as recently as Q4 2024.

Astoria Portfolio Advisors first reported a position in BMY in Q4 2023 and has held it in 6 quarters since. The position peaked at $342K in Q4 2024. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Astoria Portfolio Advisors held 3,611 shares of Bristol-Myers Squibb worth $208K as of Q2 2026.
  • Bristol-Myers Squibb was a new Astoria Portfolio Advisors position in Q2 2026.
  • Bristol-Myers Squibb made up 0.04% of Astoria Portfolio Advisors's portfolio in Q2 2026, its #340 holding.
  • Astoria Portfolio Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 6 quarters since.
  • Astoria Portfolio Advisors's Bristol-Myers Squibb position peaked at $342K in Q4 2024.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Astoria Portfolio Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.